These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19568249)

  • 1. Connective tissue diseases: Is combined oral contraceptive use linked to SLE incidence?
    Mok CC
    Nat Rev Rheumatol; 2009 Jul; 5(7):360-1. PubMed ID: 19568249
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined oral contraceptive use and the risk of systemic lupus erythematosus.
    Bernier MO; Mikaeloff Y; Hudson M; Suissa S
    Arthritis Rheum; 2009 Apr; 61(4):476-81. PubMed ID: 19333988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE.
    Julkunen HA
    Scand J Rheumatol; 1991; 20(6):427-33. PubMed ID: 1771400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic lupus erythematosus and contraception: A systematic literature review].
    Gensous N; Doassans-Comby L; Lazaro E; Duffau P
    Rev Med Interne; 2017 Jun; 38(6):358-367. PubMed ID: 28161112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
    Mendel A; Bernatsky S; Pineau CA; St-Pierre Y; Hanly JG; Urowitz MB; Clarke AE; Romero-Diaz J; Gordon C; Bae SC; Wallace DJ; Merrill JT; Buyon J; Isenberg DA; Rahman A; Ginzler EM; Petri M; Dooley MA; Fortin P; Gladman DD; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Mackay M; Alarcón G; Manzi S; Nived O; Jönsen A; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim S; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Sanchez-Guerrero J; Bruce IN; Costedoat-Chalumeau N; Vinet E
    Rheumatology (Oxford); 2019 Jul; 58(7):1259-1267. PubMed ID: 30753683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and recurrence rate in women with venous thromboembolism during combined hormonal contraceptive use: a prospective cohort study.
    van Vlijmen EF; Mäkelburg AB; Knol HM; Tichelaar VI; Kluin-Nelemans HC; Veeger NJ; Meijer K
    Br J Haematol; 2016 Feb; 172(4):636-8. PubMed ID: 26105591
    [No Abstract]   [Full Text] [Related]  

  • 7. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O; Spinar J; Musil V; Pozdísek Z
    Vnitr Lek; 2010 May; 56(5):370-5. PubMed ID: 20578585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolic events.
    Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
    J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill: another report.
    Miller MH
    Ann Rheum Dis; 1987 Feb; 46(2):159-61. PubMed ID: 3827339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD; Lawrenson RA
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review.
    Culwell KR; Curtis KM; Del Carmen Cravioto M
    Obstet Gynecol; 2009 Aug; 114(2 Pt 1):341-353. PubMed ID: 19622996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
    Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
    BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with oral contraceptives. Swiss consensus conference on frequently discussed questions about hormonal contraception].
    Strobel E
    Fortschr Med; 1992 Jul; 110(20):369-70. PubMed ID: 1521840
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease.
    Gaspard UJ; Lefebvre PJ
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):334-43. PubMed ID: 2196805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Query about Faculty updated UKMEC.
    Lee DJ
    J Fam Plann Reprod Health Care; 2010 Jul; 36(3):181; author reply 181. PubMed ID: 20659387
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute myocardial infarction due to oral contraceptive.
    Kocabay G; Yildiz M; Ozkan M
    Clin Appl Thromb Hemost; 2009; 15(3):364-5. PubMed ID: 19562835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension and contraception].
    Perol S; Hugon-Rodin J; Plu-Bureau G
    Presse Med; 2019 Nov; 48(11 Pt 1):1269-1283. PubMed ID: 31757732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions with hormonal contraception.
    Guillebaud J
    J Fam Plann Reprod Health Care; 2005 Oct; 31(4):335-6; author reply 336. PubMed ID: 16274570
    [No Abstract]   [Full Text] [Related]  

  • 19. [Basic principles of hormonal contraception].
    Birkhäuser M
    Ther Umsch; 2009 Feb; 66(2):67-9. PubMed ID: 19274855
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.